Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
Rahul Batra, Luis Gonzalez Olivieri, Rubin Delfin, et al.
Journal of Clinical Virology (2020) Vol. 132, pp. 104645-104645
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Point-of-care diagnostics for infectious diseases: From methods to devices
Chao Wang, Mei Liu, Zhifei Wang, et al.
Nano Today (2021) Vol. 37, pp. 101092-101092
Open Access | Times Cited: 414
Antibody tests for identification of current and past infection with SARS-CoV-2
Tilly Fox, Julia Geppert, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 176
Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens
Carlota Dobaño, Marta Vidal, Rebeca Santano, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 2
Open Access | Times Cited: 79
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study
Maya Moshe, Anna Daunt, Barnaby Flower, et al.
BMJ (2021), pp. n423-n423
Open Access | Times Cited: 63
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Kene David Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Emergence of infectious diseases and role of advanced nanomaterials in point-of-care diagnostics: a review
Kalaimani Markandan, Yong Wei Tiong, Revathy Sankaran, et al.
Biotechnology and Genetic Engineering Reviews (2022) Vol. 40, Iss. 4, pp. 3438-3526
Closed Access | Times Cited: 32
COVID-19 Antibody Detecting Rapid Diagnostic Tests Show High Cross-Reactivity When Challenged with Pre-Pandemic Malaria, Schistosomiasis and Dengue Samples
Fien Vanroye, Dorien Van den Bossche, Isabel Brosius, et al.
Diagnostics (2021) Vol. 11, Iss. 7, pp. 1163-1163
Open Access | Times Cited: 33
Aptamer-based biosensors and their implications in COVID-19 diagnosis
Mukti Mandal, Nirmita Dutta, Gorachand Dutta
Analytical Methods (2021) Vol. 13, Iss. 45, pp. 5400-5417
Closed Access | Times Cited: 32
Integrating Water Purification with Electrochemical Aptamer Sensing for Detecting SARS-CoV-2 in Wastewater
Payel Sen, Zijie Zhang, Phoebe Li, et al.
ACS Sensors (2023) Vol. 8, Iss. 4, pp. 1558-1567
Closed Access | Times Cited: 13
Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers
Nina Lagerqvist, Kimia T. Maleki, Jenny Verner‐Carlsson, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health
Luigi Vimercati, Pasquale Stefanizzi, Luigi De Maria, et al.
Environmental Research (2021) Vol. 195, pp. 110793-110793
Open Access | Times Cited: 30
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases
Nastya Kharlamova, Nicky Dunn, Sahl Khalid Bedri, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26
Evaluation of the performance of SARS‐­CoV­‐2 antibody assays for a longitudinal population­based study of COVID‐­19 spread in St. Petersburg, Russia
Антон Барчук, Daniil Shirokov, Maria V. Sergeeva, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 10, pp. 5846-5852
Open Access | Times Cited: 21
Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA)
Julia Klüpfel, Rosa Carolina Koros, Kerstin Dehne, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 413, Iss. 22, pp. 5619-5632
Open Access | Times Cited: 18
Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum
Manuel Krone, Julia Gütling, Johannes Wagener, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 8
Open Access | Times Cited: 16
A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19
Juan Jeferson Vilca-Alosilla, Mayron Antonio Candia-Puma, Katiusca Coronel-Monje, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1549-1549
Open Access | Times Cited: 6
Assesment of SARS-CoV-2 infection-in dentists and supporting staff at a university dental hospital in Argentina
Sebastián Ariel Puia, Jorge Pasart, Ariel Gualtieri, et al.
Journal of Oral Biology and Craniofacial Research (2021) Vol. 11, Iss. 2, pp. 169-173
Open Access | Times Cited: 13
Clinical performance evaluation of a SARS-CoV-2 Rapid Antibody Test for determining past exposure to SARS-CoV-2
Peter Findeisen, H. Stiegler, Eloisa Lopez‐Calle, et al.
International Journal of Infectious Diseases (2020) Vol. 103, pp. 636-641
Open Access | Times Cited: 13
Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK
Naheed Choudhry, Kate Drysdale, Carla Usai, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 12
Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay
Mamdouh Sibai, Daniel Solis, Katharina Röltgen, et al.
Journal of Clinical Virology (2021) Vol. 139, pp. 104818-104818
Open Access | Times Cited: 10
Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute
Tom Lutalo, Aminah Nalumansi, Denis Olara, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 281-287
Open Access | Times Cited: 9
Seroprevalence of SARS-CoV-2 (COVID-19) among Health Care Workers in Three Health Facilities of Yaounde, Center Region of Cameroon
Philippe Salomon Nguwoh, Akenji Blaise Mboringong, Joseph Fokam, et al.
European Journal of Medical and Health Sciences (2021) Vol. 3, Iss. 6, pp. 89-94
Open Access | Times Cited: 6
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals
Johannes Hayer, Eva Urlaub
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Evaluation of the Abbott Architect, Roche Elecsys and Virtus S1 SARS-CoV-2 antibody tests in community-managed COVID-19 cases
Sebastian L. Johnston, Paul F. McKay, Tatiana Kebadze, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases
Nastya Kharlamova, Nicky Dunn, Sahl Khalid Bedri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top